DCBO DCBO
Company Profile ↓Company Overview
DCBO (DCBO) is a publicly traded company listed on with a market capitalization of $585.29M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 50.6%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 29.5%.
Net profit has compounded at 74.8% per year over the last five years.
Revenue has grown at a 19.3% CAGR over the past five years.
Trades at an undemanding P/E of 15.9.
Maintains a net profit margin of 15.5%.
Recent Developments
- Dec 2025 Revenue of $242.69M (+11.9% YoY); net profit $37.51M.
- Trailing 12 Months Year-on-year growth — revenue +11.9%, earnings +40.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 19.3%, profit CAGR 74.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 19.31% |
| 1 Year: | 11.87% |
Compounded Profit Growth
| 5 Years: | 74.84% |
| 1 Year: | 40.31% |
Stock Price Performance
| 1 Year: | -32.89% |
| 6 Months: | +6.93% |
| 3 Months: | +0.15% |
| 1 Month: | +8.53% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.40 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 50.6%.
- Healthy ROCE of 29.5%.
- Compounding revenue at 19.3% over 5 years.
- Profit CAGR of 74.8% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 36.8% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 57.30M | 60.73M | 61.62M | 63.04M | 65.62M |
| Cost of Revenue | - | 11.39M | 11.58M | 12.13M | 12.74M | 14.35M |
| Gross Profit | - | 45.90M | 49.15M | 49.49M | 50.30M | 51.27M |
| Operating Expenses | - | 44.07M | 44.07M | 41.35M | 40.88M | 51.31M |
| Operating Income | - | 1.83M | 5.08M | 8.14M | 9.42M | -39.00K |
| EBITDA | - | 3.19M | 5.56M | 9.03M | 10.00M | 641.00K |
| Interest Expense | - | 31.00K | 26.00K | 45.00K | 44.00K | 622.00K |
| Pretax Income | - | 2.36M | 4.68M | 8.25M | 9.16M | -1.90M |
| Tax Provision | - | 883.00K | 1.61M | 2.14M | -17.69M | -284.00K |
| Net Income | - | 1.47M | 3.08M | 6.11M | 26.85M | -1.62M |
| Diluted EPS | - | 0.05 | 0.10 | 0.21 | 0.91 | -0.06 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 142.91M | 180.84M | 216.93M | 242.69M |
| Cost of Revenue | 28.18M | 34.50M | 41.30M | 47.85M |
| Gross Profit | 114.73M | 146.34M | 175.64M | 194.84M |
| Operating Expenses | 121.66M | 145.66M | 156.73M | 170.36M |
| Operating Income | -6.93M | 680.00K | 18.91M | 24.48M |
| EBITDA | 10.49M | 8.28M | 27.28M | 27.78M |
| Interest Expense | 376.00K | 296.00K | 185.00K | 146.00K |
| Pretax Income | 7.78M | 4.85M | 23.71M | 24.45M |
| Tax Provision | 764.00K | 2.01M | -3.02M | -13.07M |
| Net Income | 7.02M | 2.84M | 26.74M | 37.51M |
| Diluted EPS | 0.21 | 0.08 | 0.86 | 1.28 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 283.67M | 158.38M | 190.71M | 206.65M |
| Current Assets | - | 263.58M | 127.15M | 154.24M | 151.52M |
| Cash & Equivalents | - | 216.29M | 71.95M | 92.54M | 74.04M |
| Inventory | - | - | - | - | - |
| Receivables | - | 29.13M | 36.35M | 39.27M | 45.47M |
| Total Liabilities | - | 91.46M | 107.65M | 132.95M | 132.56M |
| Current Liabilities | - | 84.36M | 100.65M | 128.60M | 123.80M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 3.07M | 2.11M | 1.50M | 2.56M |
| Total Equity | - | 192.21M | 50.72M | 57.76M | 74.09M |
| Shares Outstanding | - | 32.91M | 30.31M | 30.26M | 28.75M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.29M | 15.96M | 29.25M | 28.17M |
| Investing Cash Flow | - | -2.25M | -9.52M | -1.50M | -1.84M |
| Financing Cash Flow | - | 1.67M | -151.00M | -6.84M | -46.65M |
| Capital Expenditure | - | -1.08M | -635.00K | -1.25M | -981.00K |
| Free Cash Flow | - | 1.21M | 15.33M | 28.00M | 27.19M |
| Net Change in Cash | - | 1.72M | -144.56M | 20.91M | -20.31M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 80.3% | 80.9% | 81.0% | 80.3% |
| Operating Margin % | -4.8% | 0.4% | 8.7% | 10.1% |
| Net Margin % | 4.9% | 1.6% | 12.3% | 15.5% |
| ROE % | 3.7% | 5.6% | 46.3% | 50.6% |
| ROCE % | -3.5% | 1.2% | 30.4% | 29.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DCBO
Docebo management to present in Boston, New York and virtually - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxObmJlVk03TS1sSFFpbHVDYWtjWlQtNzFEWkhORFBHNXJHTWQyRXFZWGJINkVWNXAzSVZPeGlCZ0VMU3dZb01LOWJtTFVsRmpkLUpyV3Bvb1RVOHBpbjdJVS1nakdkRUszUnNaZzU5VUZjNUtoNW9CZkxOVEJoajRnWnB6V1hBbEpkeVdCVE…
Arrowstreet Capital Limited Partnership Has $10.78 Million Stock Holdings in Docebo Inc. $DCBO - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQZTdZQVZIYnZCV3lyaC1sNVNVWFMzMjNiYzc1NzFjdGRKcFVkS0E3Z0hpS1JkY20zTHd2Mjc2dGtKNUtjb0ktTW9GU3BLZ251QlBLSnFSUGFVMml2YzRKZmtBUnNnYzJ4UUhVNlpkQWN0eU9Vd09jOWtrenRJWklNdzBHclJWX0pEREpXVE…
3 Reasons Growth Investors Will Love Docebo (DCBO) - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPUGJlMHVuejJLYURFd213d0J2aUtINHFkcjZjajdZWE5JM1NSb25VaG51ZFU5eGhyQXBBZG0yYVhWeUpNc1duMnh1UU4tdGJ3OElGRV9PUmQ0T2RoaHVxV0RkN05abGVxWTlibExwZ3NaaDhKeWNNbVJnNkt0TXpXWnloaDdSQXlGV2stcU…
AI Stocks With Recurring Revenue and Real Enterprise Demand - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOTUlTZmlCZnh2Tk1qVU0tdUNnaWo2VzFFRlRCTW40SHRWdnBPeHlaLXVaVXp4Mkx1amY2aG82SlN1TXFXamJFdDV6VVFYR3FBVWJVRmhHZThRVmNvXzczYURXY041QUJqWmRLbWZEbUllSTJPRWQ3a0lLanY2V3NpXzQtZHpVVFpka0daT3…
Precision Trading with Docebo Inc. (DCBO) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPWUZ0WC1ueHBQcEp4UDJsZU5LQ3NFM1RhUU15bnBhQmJlNmNMMVcxX0gzRGVjUHJXOFhrdk9HRUg4OVhOOEdrTGNlNEE5cDVSa0plTHZVSzBFb3JYeVNLUnhNZlhEbFotaVMzYnprQXI5SGs0SDJMck4xNzZqM1MzTEd1amdfQnJyYlU5U2…
Docebo opens offer for up to 3.43M shares, expiring Aug. 26 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOZ1hUUmpXRnBGNVdMQlRtZHhxWEp4cFZtR3BnUXV0N0RoQXhOcFdISjAtWmtkMy1Ya0JnOXNuOUYtYjZVbnYtcXF1SHdfU0xwQWlJbFhoMWZhQzdMUnNLcXZSa1VCaXdWakxZb0xSZi1odmdQMTgzb3pGREVvemV3dlNtYzgzZDJDa2hDc3…
DCBO — Frequently Asked Questions
What is the current share price of DCBO?
As of 2026-08-05 17:25 PDT, DCBO trades at $20.36 on NASDAQ/NYSE. Its 52-week range is $14.70 to $32.20.
What is the market capitalisation of DCBO?
DCBO has a market capitalisation of $585.29M on NASDAQ/NYSE.
What is the P/E ratio of DCBO?
DCBO trades at a trailing price-to-earnings (P/E) ratio of 15.91. Its price-to-book (P/B) ratio is 7.90.
What is the return on equity (ROE) of DCBO?
DCBO has a return on equity (ROE) of 50.63%. Its return on capital employed (ROCE) is 29.55%.
Is DCBO a good stock to buy?
This page provides a data-driven analysis of DCBO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.